Hubei Biocause Pharmaceutical Co., Ltd. (SHE:000627)

China flag China · Delayed Price · Currency is CNY
3.810
-0.030 (-0.78%)
Apr 1, 2025, 2:45 PM CST
54.25%
Market Cap 18.97B
Revenue (ttm) 40.70B
Net Income (ttm) -771.87M
Shares Out 4.94B
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,000,604
Average Volume 105,733,228
Open 3.940
Previous Close 3.840
Day's Range 3.800 - 3.940
52-Week Range 1.610 - 5.420
Beta 0.63
RSI 43.10
Earnings Date Apr 29, 2025

About SHE:000627

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and inter... [Read more]

Sector Financials
CEO Wenxia Zhou
Employees 1,765
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000627
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.